Cell detachment modulates TRAIL resistance in ovarian cancer cells by downregulating the phosphatidylinositol 3-kinase/Akt pathway
- PMID: 17868340
- DOI: 10.1111/j.1525-1438.2007.01062.x
Cell detachment modulates TRAIL resistance in ovarian cancer cells by downregulating the phosphatidylinositol 3-kinase/Akt pathway
Abstract
TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) is a potent inducer of apoptosis but many ovarian cancer cells display intrinsic resistance to TRAIL. The molecular determinants regulating TRAIL sensitivity in these resistant tumor cells are still incompletely understood. We observed that cell detachment enhances TRAIL-induced apoptosis in two TRAIL-resistant ovarian cancer cell lines. This process was accompanied by an increase of caspase activation, which could be blocked by caspase-8 inhibitor IETD. Cell detachment inhibited Akt phosphorylation. Phosphatidylinositol 3-kinase inhibition by LY294002 also enhanced TRAIL-induced apoptosis. Further decreased Akt activity by LY294002 in detached cells translated to increased cell death after TRAIL treatment. Our data indicate that cell detachment enhances TRAIL-induced killing by decreasing Akt activity in TRAIL-resistant ovarian carcinoma cells and suggest that Akt inhibition primes TRAIL-resistant cells to TRAIL-induced apoptosis.
Similar articles
-
Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells.Int J Cancer. 2007 Sep 15;121(6):1227-37. doi: 10.1002/ijc.22840. Int J Cancer. 2007. PMID: 17534891
-
Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway.Oncol Rep. 2011 Dec;26(6):1573-9. doi: 10.3892/or.2011.1423. Epub 2011 Aug 17. Oncol Rep. 2011. PMID: 21850380
-
Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation.Cell Death Differ. 2004 Dec;11(12):1287-98. doi: 10.1038/sj.cdd.4401489. Cell Death Differ. 2004. PMID: 15297884
-
Role of the Akt pathway in prostate cancer.Curr Cancer Drug Targets. 2009 Mar;9(2):163-75. doi: 10.2174/156800909787581006. Curr Cancer Drug Targets. 2009. PMID: 19275757 Review.
-
The Gerhard Zbinden Memorial Lecture. Alteration of cell signalling in chemical toxicity.Arch Toxicol Suppl. 1996;18:3-11. doi: 10.1007/978-3-642-61105-6_1. Arch Toxicol Suppl. 1996. PMID: 8678806 Review. No abstract available.
Cited by
-
TRAIL-coated leukocytes that prevent the bloodborne metastasis of prostate cancer.J Control Release. 2016 Feb 10;223:215-223. doi: 10.1016/j.jconrel.2015.12.048. Epub 2015 Dec 28. J Control Release. 2016. PMID: 26732555 Free PMC article.
-
TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development.J Clin Invest. 2008 Jan;118(1):100-10. doi: 10.1172/JCI33061. J Clin Invest. 2008. PMID: 18079967 Free PMC article.
-
TRAIL-mediated apoptosis in breast cancer cells cultured as 3D spheroids.PLoS One. 2014 Oct 24;9(10):e111487. doi: 10.1371/journal.pone.0111487. eCollection 2014. PLoS One. 2014. PMID: 25343626 Free PMC article.
-
Intracellular localization of DR5 and related regulatory pathways as a mechanism of resistance to TRAIL in cancer.Cell Mol Life Sci. 2017 Jan;74(2):245-255. doi: 10.1007/s00018-016-2321-z. Epub 2016 Aug 10. Cell Mol Life Sci. 2017. PMID: 27510421 Free PMC article. Review.
-
The Anti-Proliferative Effect of PI3K/mTOR and ERK Inhibition in Monolayer and Three-Dimensional Ovarian Cancer Cell Models.Cancers (Basel). 2022 Jan 13;14(2):395. doi: 10.3390/cancers14020395. Cancers (Basel). 2022. PMID: 35053555 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical